Target intelligence / Profile preview

Zinc finger protein 432 (ZNF432)

Target
ZNF432
Molecular classification
Transcription factor, DNA-binding protein, C2H2-type zinc finger protein
01

Overview

Zinc finger protein 432 (ZNF432) is a human protein encoded by the ZNF432 gene, classified in the C2H2-type zinc finger protein family. ZNF432 is characterized as a DNA-binding transcription factor that acts as a homologous recombination repressor and a poly(ADP-ribose) (PAR) "reader," dynamically participating in DNA damage response pathways. Mechanistically, ZNF432 is recruited to DNA lesions in a DNA- and parylation-dependent manner, where it can stimulate PARP1 activity and inhibit Exo1-mediated DNA end-resection, contributing to the regulation of genome stability. Experimental depletion of ZNF432 has been shown to increase Rad51 foci and alter DNA repair pathway engagement, confer resistance to PARP inhibition, and potentially impact cancer therapy outcomes. The protein is located in the nucleoplasm, and its dysregulation has been associated with roles in cancer development and inflammatory disorders such as inflammatory bowel disease, although the precise disease link remains to be further explored[3][1][4][2].

Other names
Zinc finger protein 432ZNF432KIAA0798
02

Mechanism of action

Potential modulation of PARP inhibitor sensitivity via inhibition of Exo-1–mediated DNA end-resection and stimulation of PARP1 activity[1][4]

03

Biological functions

DNA damage responseHomologous recombination repressionRegulation of DNA end-resectionPARP1 activationTranscription regulation
04

Disease associations

CancerInflammatory Bowel DiseaseDrug resistance (specifically, resistance to PARP inhibition in cancer therapy)

Beyond the preview

Go deeper on Zinc finger protein 432 (ZNF432).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 432 (ZNF432).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call